Article

Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosis

2023-01-23

Abstract excerpt

Amyotrohpic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes generalized muscle weakness and atrophy. Neuropathologically, ALS is defined by severe loss of upper and lower motor neurons with a robust neuroinflammatory response. In the present study, we have examined the potential utility of two drugs that have indications as immune modulators, levamisole HCl and thymosin α1. These dru...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e6e1806-f12c-5f5b-82da-f55d0f349a76
DOI: 10.1101/2023.01.23.525258

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosisDOI 10.1101/2023.01.23.525258Read

A Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with Amyotrophic Lateral Sclerosis (ALS Protocol GALS-001) and a single compassionate patient treatment (Protocol GALS-C)Semantic proximity Read

Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.Semantic proximity Read

Preclinical testing of potential therapeutics for Amyotrophic Lateral SclerosisSemantic proximity Read

Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.Semantic proximity Read

Therapeutic advances in amyotrophic lateral sclerosis.Semantic proximity Read

Intranasal Dantrolene Nanoparticles for Treatment of Amyotrophic Lateral Sclerosis as a Disease-Modifying DrugSemantic proximity Read

Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisSemantic proximity Read

A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis.Semantic proximity Read

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.Semantic proximity Read

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.Semantic proximity Read

Safety evaluation of a potential anti-rheumatoid arthritis candidate, levamisoleSemantic proximity Read

Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations.Semantic proximity Read